The liberals demanding pharmaceutical price controls, and the Republicans warming to the idea, have moved on from their outrage over the Hepatitis C cure that debuted two years ago. Perhaps that’s because their fury was entirely synthetic—as even Democrats on the Senate Finance Committee now concede.
Read Full Article »
